Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
The American Journal of Medicine
|
February 8, 1985
Aztreonam: the first monobactam
R B Sykes, D P Bonner
Reviews of Infectious Diseases
|
November 1, 1985
Discovery and development of the monobactams
R B Sykes, D P Bonner
British Medical Bulletin
|
January 1, 1984
Counteracting antibiotic resistance: new drugs
R B Sykes, D P Bonner
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
The versatile monobactam family: new agents addressing specific needs in infectious disease
D P Bonner, W H Koster
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1983
Prediction of aztreonam pharmacokinetics in humans based on data from animals
E A Swabb, D P Bonner
The Journal of Antimicrobial Chemotherapy
|
October 1, 1984
Structure activity relationships among the monobactams
D P Bonner, R B Sykes
Expert Opinion on Investigational Drugs
|
February 1, 1997
Recent developments in pradimicin-benanomicin and triazole antibiotics
J C Fung-Tomc, D P Bonner
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
The versatile monobactam family: manipulation of intrinsic activity and in vivo efficacy via N-1 activating group modification
W H Koster, D P Bonner, R Zahler
Antimicrobial Agents and Chemotherapy
|
June 1, 1993
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus
J Fung-Tomc, B Kolek, D P Bonner
The Journal of Antibiotics
|
February 1, 1975
Stability studies with amphotericin B and amphotericin B methyl ester
D P Bonner, W Mechlinski, C P Schaffner
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
The American Journal of Medicine
|
February 8, 1985
Aztreonam: the first monobactam
R B Sykes, D P Bonner
Reviews of Infectious Diseases
|
November 1, 1985
Discovery and development of the monobactams
R B Sykes, D P Bonner
British Medical Bulletin
|
January 1, 1984
Counteracting antibiotic resistance: new drugs
R B Sykes, D P Bonner
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
The versatile monobactam family: new agents addressing specific needs in infectious disease
D P Bonner, W H Koster
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1983
Prediction of aztreonam pharmacokinetics in humans based on data from animals
E A Swabb, D P Bonner
The Journal of Antimicrobial Chemotherapy
|
October 1, 1984
Structure activity relationships among the monobactams
D P Bonner, R B Sykes
Expert Opinion on Investigational Drugs
|
February 1, 1997
Recent developments in pradimicin-benanomicin and triazole antibiotics
J C Fung-Tomc, D P Bonner
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
The versatile monobactam family: manipulation of intrinsic activity and in vivo efficacy via N-1 activating group modification
W H Koster, D P Bonner, R Zahler
Antimicrobial Agents and Chemotherapy
|
June 1, 1993
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus
J Fung-Tomc, B Kolek, D P Bonner
The Journal of Antibiotics
|
February 1, 1975
Stability studies with amphotericin B and amphotericin B methyl ester
D P Bonner, W Mechlinski, C P Schaffner
Page
of 7